Brief: Elicio Presents Preclinical Data On AMP TCR-T Combination Therapy In Solid Tumors At CAR-TCR Annual Summit 2021
10/09/2021 13:17
Sept 10 (Reuters) - Elicio Therapeutics Inc ELTX.O :
* PRESENTS PRECLINICAL DATA ON AMP TCR-T COMBINATION THERAPY
IN
SOLID TUMORS AT CAR-TCR ANNUAL SUMMIT 2021
Source text for Eikon: ID:nGNX9r3ndK
Further company coverage: ELTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elicio Therapeutics
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Elicio Therapeutics Q2 net loss narrows as R&D expenses fall
Elicio Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
Elicio shares slide after pancreatic cancer vaccine falls short in mid-stage study (updated)